comparemela.com

Latest Breaking News On - Phar - Page 5 : comparemela.com

Exclusive: Delays getting higher dose Wegovy to patients reported by US doctors

Some U.S. patients taking the two highest doses of Novo Nordisk's Wegovy weight-loss drug are facing difficulty filling their prescriptions, eight doctors around the country told Reuters this week, suggesting a new supply challenge for the popular medicine.

Exclusive: MoonLake Immunotherapeutics explores sale-sources

MoonLake Immunotherapeutics , a developer of an antibody-derived treatment for inflammatory skin conditions, is exploring a sale, according to people familiar with the matter.

U S watchdog lifts price estimate for Bluebird, Vertex/CRISPR gene therapies to $2 1 mln

An influential U.S. drug pricing watchdog raised the price estimate of two experimental gene therapies from Vertex Pharmaceuticals /CRISPR Therapeutics and bluebird bio to as much as $2.05 mln, saying the new price can be cost effective to treat sickle cell disease.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.